Maripau Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Maripau Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,742	Closed	-$256K	–	79
2022 Q1	$256K	Sell	4,742 -911	-16%	-$57.5K	0.23%	75
2021 Q4	$368K	Buy	+5,653	New	+$475K	0.35%	61

Other funds holding GNOM

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Maripau Wealth Management's GNOM Position: Q2 2022 in Review

Maripau Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2022, closing a stake of 4,742 shares — an estimated $256K sold.

Maripau Wealth Management first reported a position in GNOM in Q4 2021 and held it in 2 quarters. The position peaked at $368K in Q4 2021. 58 funds tracked by Wall St. Rank hold GNOM as of Q2 2022.

Maripau Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Maripau Wealth Management sold 4,742 Global X Genomics & Biotechnology ETF shares in Q2 2022, an estimated $256K.
Maripau Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and held it in 2 quarters.
Maripau Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $368K in Q4 2021.
58 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2022.

Based on Maripau Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.